Prime Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-204.5	-198.13	-142.01	-184.12	-5.06
Depreciation & Amortization	18.22	17.44	12.01	4.86	0.04
Share-Based Compensation	17.44	13.91	6.46	1.75	0.39
Other Operating Activities	-22.72	1.37	-28.48	124.68	-2.57
Operating Cash Flow	-191.56	-165.41	-131.83	-34.08	-5.54
Capital Expenditures	-9.05	-8.72	-16.1	-4.15	-0.64
Change in Investments	3.56	27.61	-30.34	-68.98	0
Other Investing Activities	-0.17	-0.17	-0.67	-0.5	-0.42
Investing Cash Flow	-5.66	18.71	-47.1	-73.63	-1.06
Share Issuance / Repurchase	151.91	0.66	185.54	0	0
Other Financing Activities	6	-	-4.04	269.28	34.93
Financing Cash Flow	157.91	0.66	181.49	269.28	34.93
Net Cash Flow	-39.3	-146.05	2.57	161.57	28.33
Free Cash Flow	-200.61	-174.14	-147.92	-38.23	-6.18
Free Cash Flow Margin	-33943.65%	-	-	-	-118.68%
Free Cash Flow Per Share	-1.92	-1.91	-4.37	-2.95	-2.34

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).